Xencor
The Associate Director leads the end-to-end execution of global clinical trials for early- to late-stage programs, coordinating cross-functional teams and external vendors to ensure studies meet timelines and budgets. This role requires hands-on management of study performance metrics, protocol reviews, and vendor oversight while maintaining strict compliance with regulatory standards. The position involves strategic planning for site selection, patient enrollment, and process improvements within the biopharmaceutical industry.
Headquarters
Pasadena, California, United States
Company Size
201-500 employees
Founded
1997
Xencor is a clinical-stage biopharmaceutical company that designs engineered proteins to create novel biologic medicines. Using proprietary protein-design platforms (including XmAb Fc engineering and cytokine/antibody engineering), Xencor builds next‑generation monoclonal antibodies, bispecifics and cytokine therapeutics with improved potency, half‑life and safety. The company advances an internal pipeline across oncology and immune‑mediated diseases while partnering with other biopharma organizations to discover and develop therapeutics. Xencor emphasizes rational protein design and translational science to deliver differentiated medicines to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Xencor.
17% above the average for this role
Clinical Trial Manager
Structure Therapeutics
Clinical Trial Start‑up Lead
Entrada Therapeutics
Clinical Trial Manager/Senior Clinical Trial Manager
Equilliumbio
Senior Clinical Trial Manager
Generate:Biomedicines
Clinical Trial Manager
Lakefront Biotherapeutics
Clinical Trial Manager/Senior Clinical Trial Manager
Lexeo Therapeutics